Endometrial Effects of SERMs
S Palacios - Selective Estrogen Receptor Modulators: A New Brand …, 2006 - Springer
SERMs (Selective Estrogen Receptor Modulators) are compounds with a molecular
structure different from that of steroids. They share with steroids their selective binding to …
structure different from that of steroids. They share with steroids their selective binding to …
[PDF][PDF] Efectividad de la cirugía profiláctica, la quimioprevención y la vigilancia intensiva en mujeres portadoras de mutaciones en los genes BRCA 1 y 2
MJ Bermejo Pérez - 2006 - digibug.ugr.es
UNIVERSIDAD DE GRANADA Efectividad de la cirugía profiláctica, la quimioprevención y
la vigilancia intensiva en mujeres porta Page 1 UNIVERSIDAD DE GRANADA TESIS …
la vigilancia intensiva en mujeres porta Page 1 UNIVERSIDAD DE GRANADA TESIS …
The protection against trimetrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-fluorouracil/trimetrexate
JR Das, EB Fryar, S Green, WM Southerland… - Anticancer …, 2006 - ar.iiarjournals.org
Background: Currently, one of the most effective strategies for the treatment and prevention
of breast cancer is the use of drugs that block estrogen action in the breast. The success of …
of breast cancer is the use of drugs that block estrogen action in the breast. The success of …
Indications du raloxifène chez la femme ménopausée
F Trémollières, C Ribot - Gynécologie obstétrique & fertilité, 2006 - Elsevier
Résumé La prise en charge de la phase postménopausique s' est profondément modifiée
au cours de ces dernières années, après les résultats des études WHI et MWS témoignant …
au cours de ces dernières années, après les résultats des études WHI et MWS témoignant …
Current status of breast cancer chemoprevention
VM Oliveira, JM Aldrighi, JF Rinaldi - Revista da Associação Médica …, 2006 - SciELO Brasil
Quimioprevenção é definida como o uso de agentes químicos naturais ou sintéticos para
reverter, suprimir ou prevenir a progressão carcinogênica para carcinoma invasor. Os …
reverter, suprimir ou prevenir a progressão carcinogênica para carcinoma invasor. Os …
The role of SERMs in the management of postmenopausal women
J Calaf i Alsina - Selective Estrogen Receptor Modulators: A New Brand …, 2006 - Springer
Menopause is biological evidence of aging in women. The absence of menstruation is
clinical evidence of the inability of individual females to reproduce. However, what seems to …
clinical evidence of the inability of individual females to reproduce. However, what seems to …
[PDF][PDF] PACIENTES DE ALTO RIESGO: SEGUIMIENTO, QUIMIOPREVENCIÓN O MASTECTOMÍA PROFILÁCTICA
MJ Mattioli - revistasamas.org.ar
El cáncer de mama es el tipo más frecuente de neoplasia en el sexo femenino; se presenta
en una de cada ocho mujeres en alguna etapa de su vida. A pesar del diagnóstico y los …
en una de cada ocho mujeres en alguna etapa de su vida. A pesar del diagnóstico y los …
Commentary on mobley and others: Importance of assumptions about VTE mortality in modeling the cost-effectiveness of osteoporosis therapies
ES Meadows, J Stock… - Medical decision making, 2006 - journals.sagepub.com
Treatment with Hormone Replacement Therapy, Raloxifene, or Alendronate” by Mobley and
colleagues in the March–April 2006 issue of Medical Decision Making. 1 In this study, the …
colleagues in the March–April 2006 issue of Medical Decision Making. 1 In this study, the …
Prevention of breast cancer
M Morrow, VC Jordan - Breast Cancer and Molecular Medicine, 2006 - Springer
Considerable progress has been made in understanding the mechanisms of breast tumor
growth and progression. Application of effective treatment practices has resulted in …
growth and progression. Application of effective treatment practices has resulted in …
Die Entwicklung der Bisphosphonate—ein Meilenstein in der Osteoporosetherapie
W Fassbender, U Stumpf, A Kurth - Medizinische Klinik-Intensivmedizin …, 2006 - infona.pl
Bisphosphonate sind eine Gruppe osteotroper Substanzen, die in den letzten 30 Jahren
erfolgreich bei verschiedenen Knochenerkrankungen eingesetzt werden. Seit über einer …
erfolgreich bei verschiedenen Knochenerkrankungen eingesetzt werden. Seit über einer …